A-286501 is a potent and orally active adenosine kinase inhibitor with analgesic and anti-inflammatory effects; it reduces nociceptive responses in rodent models of acute (thermal), inflammatory (formalin and carrageenan), and neuropathic (L5/L6 nerve ligation and streptozotocin-induced diabetic) pain; it also decreases carrageenan-induced paw edema and myeloperoxidase activity; it shows potential for research as an analgesic and anti-inflammatory agent.